Adequate protein is also needed to maintain bone mass, physical function, and immune function
Evidence-based addiction medicine treatmentsincluding behavioral therapy and FDA-approved medications like naltrexoneremain the standard of care
Highly processed foods can be considered addictive substances based on established scientific criteria
Combining phentermine with semaglutide or tirzepatide is sometimes done but requires careful monitoring
Although the signaling pathways for pancreatic , , and cells are different as each cell type ultimately secretes different neuropeptides, they share similar cAMP-PKA pathways [29]
Clinical studies have shown that tirzepatide: Significantly reduces hemoglobin A1C levels compared to placebo Promotes weight loss in a dose-dependent manner May have potential benefits for non-alcoholic fatty liver disease (NAFLD) patients Tirzepatide is typically administered as follows: Once-weekly subcutaneous injection Available in various strengths (e.g., 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) Dose is usually titrated over time to reach the target dose Common side effects may include: Nausea Diarrhea Decreased appetite Vomiting Constipation Abdominal pain Tirzepatide should be used with caution in patients with: History of pancreatitis Severe gastrointestinal disease Diabetic retinopathy Pregnancy: Tirzepatide should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus
